WO2026132909 - PROCESSABLE STATINS AND USE FOR THE SAME
National phase entry is expected:
Publication Number
WO/2026/132909
Publication Date
25.06.2026
International Application No.
PCT/IB2025/000654
International Filing Date
18.12.2025
Title **
[English]
PROCESSABLE STATINS AND USE FOR THE SAME
[French]
STATINES POUVANT ÊTRE TRAITÉES ET LEUR UTILISATION
Applicants **
RIPPLE THERAPEUTICS CORPORATION
Inventors
STATHAM, Matthew, Alexander John
DAY, Jonathan
WHITTON, Gregory, Allan
BATTISTON, Kyle, Giovanni
PARRAG, Lan, Charles
SIMPSON, Madeline, Jenna
NAIMARK, Wendy, Alison
Priority Data
63/736,324
19.12.2024
US
63/736,331
19.12.2024
US
63/797,800
30.04.2025
US
63/797,807
30.04.2025
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5045 | |
| EPO | Filing, Examination, Granting | 71648 | |
| Japan | Filing, Examination, Granting | 4298 | |
| South Korea | Filing, Examination, Granting | 6685 | |
| USA | Filing, Examination, Granting | 20790 |
Total:
108,466
Contact Us
Abstract[English]
Described herein are formulations for the controlled release of statin therapies and methods related thereto.[French]
L'invention concerne des formulations pour la libération contrôlée de thérapies à base de statine et des méthodes associées.